The Increasing Incidence of Neuroendocrine Neoplasms Worldwide: Current Knowledge and Open Issues-Reference-Cited by-同舟云学术

The Increasing Incidence of Neuroendocrine Neoplasms Worldwide: Current Knowledge and Open Issues

Published:2022-06-30 Issue:13 Volume:11 Page:3794
ISSN:2077-0383
Container-title:Journal of Clinical Medicine
language:en
Short-container-title:JCM

Author:

Rossi Roberta Elisa^ORCID,Massironi Sara^ORCID

Abstract

Neuroendocrine neoplasms (NENs) include a heterogeneous group of tumors derived from neuroendocrine cells, most commonly arising from the gastro-entero-pancreatic (GEP) and bronchopulmonary tracts [...]

Publisher

MDPI AG

Subject

General Medicine

Link

https://www.mdpi.com/2077-0383/11/13/3794/pdf

Reference23 articles.

1. The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors

2. Trends in Incidence of Neuroendocrine Neoplasms in Norway: A Report of 16,075 Cases from 1993 through 2010

3. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

4. One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

5. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors associated with gastric and duodenal neuroendocrine tumors: A multicenter case-control study;Digestive and Liver Disease;2024-09

2. Real-World Study of Lanreotide Autogel in Routine Practice in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Hong Kong and Taiwan;Oncology and Therapy;2024-08-31

3. An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects;International Journal of Molecular Sciences;2024-08-06

4. Outcome of Endoscopic Resection of Rectal Neuroendocrine Tumors ≤ 10 mm;Diagnostics;2024-07-11

5. An update on the safety of lanreotide autogel for the treatment of patients with neuroendocrine tumors;Expert Opinion on Drug Safety;2024-06-10